Using Manufacturing Design Space Concepts for Stability Risk Assessment-Gabapentin NIPTE/FDA Case Study

Area of Science:

• Pharmaceutical Sciences
• Risk Assessment
• Statistical Modeling

Background:

• Ensuring pharmaceutical product stability is critical for patient safety and regulatory compliance.
• Manufacturing controls significantly impact drug product shelf life and efficacy.
• Existing methods for predicting drug stability often lack quantitative risk assessment.

Purpose of the Study:

• To evaluate a quantitative, model-based risk assessment process for pharmaceutical stability.
• To determine the probability of a gabapentin tablet formulation meeting end-of-expiry stability criteria.
• To link manufacturing controls to shelf-life failure probabilities.

Main Methods:

• Bayesian parameter estimation was employed for risk assessment.
• A design space manufacturing model and a shelf life stability model were developed.
• Monte Carlo simulations integrated model parameter uncertainty to estimate failure probabilities.

Main Results:

• The developed models successfully estimated the probability of shelf-life failure.
• Model predictions were validated against experimental long-term stability data.
• The risk assessment process demonstrated the impact of manufacturing controls on stability.

Conclusions:

• A quantitative, model-based risk assessment approach is effective for predicting pharmaceutical stability.
• Bayesian methods and linked models provide valuable insights into manufacturing control impacts.
• This framework supports robust end-of-expiry stability criteria for drug products.